UCD
Novel platform targeting aggressive and highly resistant cancers with small molecule combinations that can synergise to deliver superior treatment performance at lower toxicities. In silico simulations will be used for compound optimisation and potency predictions.
Last Updated:
Last Updated:
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...
